Sumatriptan 6 MG subcutaneous as an effective migraine treatment in patients who historically fail to respond to oral triptans

Authors
Category Primary study
JournalHeadache and Pain: Diagnostic Challenges, Current Therapy
Year 2006
This article has no abstract
Epistemonikos ID: 36887719b3a0438911058b16fdd19eaf2902b51e
First added on: Feb 04, 2025